Omega-3

The new KD-Kap omega-3 is “protected from oxidation and easily mixable in water,” according to KD Omega Health partners KD Pharma and nanoSaar.

Enzymotec says its low-sodium K-REAL krill oil now meets the criteria for a blood pressure health claim in Europe.

A new multidomain trial suggests DHA omega-3 supplementation combined with a healthy lifestyle may help maintain cognitive function in adults aged 70 and over.

A look back at some of the year’s most impactful research on dietary supplement ingredients.

Omega-3 suppliers are now taking omega-3 concentrates for dietary supplements into near-pharmaceutical territory with concentrations up to 90%, including the first high-concentrate algae oil on the market.

Sublime contains phospholipids, choline, omega-3 PUFAs, and astaxanthin.

Importantly, the researchers say, their study took care to ensure that the concentrations of EPA and DHA in the supplements administered, whether from fish oil or krill oil, were equal.

Researchers investigating omega-3s are uncovering new arenas for their broad spectrum of health effects, including some not previously explored.

The company has set a high standard for itself: a maximum-limit TOTOX value of 5 for its entire AlaskOmega line.

Could omega-3 tablets mean the end of fishy burps?

High concentrates are taking a slice of the omega-3 pie for both drugs and supplements.

Despite running up against a negative New York Times article denouncing scientific support for fish oil, the GOED-led campaign showed positive results.

A new study suggests fish oil-derived omega-3 supplements may help fight the effects of sarcopenia.

KD Pharma (Bexbach, Germany) is now officially launching the ingredient, KD Active, for the sports nutrition market.

The conference will take place in Shanghai on June 23, one day before the beginning of Fi Asia-China.

New research on oral health ingredients

The idea that krill oil has higher bioavailability than fish oil may be true, but new research suggests we need a different theory to explain why.

The Antarctic Wildlife Research Fund is ready to accept project proposals after a big financial commitment from Aker BioMarine.

Omega-3s may soon be back in the limelight thanks to a national publicity campaign by GOED.

Cargill's IngreVita EPA/DHA omega-3 oil takes a turn into non-GMO territory.

Qualitas Health discusses pursuing GRAS affirmation for food and beverage use.

Krill, menhaden, and salmon oils (both farmed and wild)-which previously were excluded-will now be included in the draft standard.

Nutritional Outlook has pegged omega-3 DHA and EPA as one of 2015's ingredients to watch. Check back daily as we release new predictions.

Although many consumers recognize the health benefits of vitamin D and omega-3s, actual usage of the supplements may not match public awareness.

So far evidence for muscle recovery, body composition, and even brain health is promising, says a leading omega-3 brand.

In just four weeks, the Always Omega-3 consumer campaign returned omega-3s to market growth in North Carolina.

Qualitas has been studying the stability of its algal oil compared to that of krill oil.

Baby food and pet food still dominate the DHA market.

Nordic Naturals says that its new Omega-3 Phospholipids has a higher phospholipid content and a broader range of phospholipids compared to krill oil.

GOED says this may influence other countries to look more favorably on long-chain omega-3 fatty acids for children.